15 Hrs
Source:
المشهد العربي
Eli Lilly targets acquisitions to grow
American company Eli Lilly plans to expand its operations through major acquisition deals, following its recent purchase of Centessa Pharmaceuticals for $7.8 billion. CEO David Ricks aims to capitalize on the high returns generated from sales of obesity and diabetes medications to direct investments toward promising sectors such as infectious diseases, women's health, and mental health, with a focus on making a tangible impact in these areas. The company also considers share repurchases and dividend distributions. This move aligns with its expansion strategy to strengthen its position as a leading global pharmaceutical entity.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)